Approval · Notice of Compliance 18344 · 2016
NIPRIDE: Notice of Compliance 18344
Issued July 26, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18344
- Date
- July 26, 2016
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To correct the dilution volumes listed on the product labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NIPRIDE | Not yet assigned | — |
Medicinal ingredients
- SODIUM NITROPRUSSIDE 25 MG per ML